NILA Applauds CRL for Launching Saliva-Based COVID-19 Test

The National Independent Laboratory Association (NILA) congratulates its member, Clinical Reference Laboratory (CRL), for its recent groundbreaking advancement in COVID-19 testing. Last month Clinical Reference Laboratory (CRL), one of the largest privately held clinical testing laboratories in the United States, received Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for CRL Rapid Response™, a saliva-based COVID-19 RT-PCR test that can be self-collected at home, at work or in other settings. CRL Rapid Response™ is the first large-scale service of its kind focused on the American workforce. The test detects the presence of COVID-19 in a saliva sample and was shown in CRL's EUA studies to be more sensitive and accurate than the COVID-19 anterior nasal swab test. Virtually anyone can self-collect an adequate sample for testing, with results available in 24-48 hours of receipt at CRL.

Click here to see the NILA news release for additional details.